Carvalho, R. F., Canto, L. M. d., Cury, S. S., Hansen, T. F., Jensen, L. H., & Rogatto, S. R. (2021). Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG.
Cita Chicago Style (17a ed.)Carvalho, Robson Francisco, Luisa Matos do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, y Silvia Regina Rogatto. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.
Cita MLA (8a ed.)Carvalho, Robson Francisco, et al. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies <i>TOP2A</i> as a Therapeutic Target for Rectal Cancer. MDPI AG, 2021.